Lead Drug Discovery


The method by which a drug is delivered can have a significant effect on its efficacy. To minimize drug degradation and loss, to prevent harmful side-effects and to increase drug bioavailability and the fraction of the drug accumulated in the required zone, various drug delivery and drug targeting systems are currently under development. Attempts are being made to develop therapeutic proteins for cancer, hepatitis, and autoimmune conditions, but their clinical applications are limited, except in the cases of drugs based on erythropoietin, granulocyte colony-stimulating factor, interferon-alpha, and antibodies, owing to problems with fundamental technologies for protein drug discovery. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology.

  • Choosing Disease and Drug Target
  • Identification of Pharmacophore
  • Lead Compounds and SAR
  • High throughput screening
  • Computer-aided drug design

Related Conference of Lead Drug Discovery

January 22-23, 2026

26th World Congress on Medicinal Chemistry and Drug Design

Bangkok, Thailand
February 25-26, 2026

16th International Conference on Chemistry Meeting

Paris, France
February 26-27, 2026

29th World Congress on Materials Chemistry

Paris, France
June 17-18, 2026

15th World Congress on Chromatography

Paris, France
August 11-12, 2026

5th World Congress on Plasma Chemistry and Plasma Processing

Amsterdam, Netherlands
September 21-22, 2026

16th International Chemistry Congress

Barcelona, Spain
November 26-27, 2026

6th International Conference on Petrochemistry and Natural Gas

Amsterdam, Netherlands

Lead Drug Discovery Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in